Table 1.
Demographics for healthy control (HC) and OCD participants.
| M/F | Mean age | Range | Height (in.) | Weight (lbs) | CY-BOCS | Comorbidities | Current Treatment | |
|---|---|---|---|---|---|---|---|---|
| Healthy controls (n = 18) | 13/5 | 17.3 (2.88) | 12-21 | 67.3 (4.8) | 154.0 (55.5) | Grooming disorder - 1 | None | |
| OCD (n = 36) | 16/20 | 16.8 (3.14) | 9-21 | 65.1 (4.4) | 139.3 (49.3) |
T: 29/18 (6.8/8.7) O: 15/9 (3.7/4.2) C: 14/9 (1.0/4.9) |
GAD – 11 Separation anxiety – 11 Grooming disorder – 11 Motor/vocaltic – 11 ADHD – 9 Social phobia – 8 Specific phobia – 6 Depression – 6 Enuress – 4 Tourette's – 2 Panic attacks/disorder – 2 Encopresis – 1 ODD – 1 Agoraphobia – 1 ASD – 1 Dysthymia – 1 |
SSRI – 18 Buspirone – 2 |
Groups did not differ in terms of age (t = 0.65, p = 0.671), height (t = 1.499, p = 0.375), weight (t = 0.918, p > 0.05), or gender (χ2 = 3.724, p > 0.05). Values in parentheses represent standard deviation. For lifetime CY-BOCS (lifetime/current): T = Total symptoms, O = Obsessive symptoms, C = Compulsive symptoms. The numbers of subjects with diagnosed comorbidities are listed. GAD: General anxiety disorder; ADHD: attention deficit hyperactivity disorder; Grooming disorder includes nail biting, skin picking; Depression includes major depressive disorder and depression not otherwise specified; ODD: oppositional defiant disorder; ASD: autism spectrum disorder. Number of subjects receiving listed treatments is also noted. SSRI: selective serotonin reuptake inhibitors, includes citalopram, sertraline, fluoxetine.